Results 91 to 100 of about 3,596 (145)

Engineered Metal–Organic Frameworks‐Based Materials for Environmental Detection

ENERGY &ENVIRONMENTAL MATERIALS, Volume 9, Issue 4, July 2026.
Engineered metal–organic frameworks (MOFs) regulated by various material modification strategies are discussed for environmental contaminant detection under different sensing mechanisms, providing future improvements of MOFs in environmental detection. Sensitive and selective detection of contaminants is crucial for environmental protection.
Pan Gao, Song Wang, Yuechao Yao, Yibo Dou   +3 more
wiley   +1 more source

Lanthanum deposition disease as a cause of gastrointestinal bleeding in a dialysis patient: a case report

Renal Replacement Therapy
Background Lanthanum carbonate (LC) is a calcium-free phosphate binder widely used in patients with chronic kidney disease, including those undergoing dialysis.
Yoshitaka Furuto, Hirotomo Koda, Daiki Yoshino, Sayako Ikeda, Akio Namikawa, Dai Sato, Teppei Morikawa, Yuko Shibuya   +7 more
doaj   +1 more source

Different Effect of Lanthanum Carbonate and Sevelamer Hydrochloride on Calcium Balance in Patients with Moderate to Advanced Chronic Kidney Disease. [PDF]

Ther Clin Risk Manag, 2021
Makowka A, Nowicki M.
europepmc   +1 more source

An open-label phase 2 trial to assess the efficacy, safety and pharmacokinetics of lanthanum carbonate in hyperphosphatemic children and adolescents with chronic kidney disease undergoing dialysis. [PDF]

BMC Nephrol, 2022
Wasilewska A, Murray RA, Sundberg A, Uddin S, Achenbach H, Shavkin A, Szabó T, Vergani A, Umeh O.   +8 more
europepmc   +1 more source

Comparison of efficacy between lanthanum carbonate and calcium acetate in reducing blood phosphorus in hemodialysis patients

Linchuang shenzangbing zazhi, 2020
随着血液透析（hemodialysis,HD）患者的逐年增多,如何延长透析患者的生命及提高其生活质量已成为全球关心的一个重要问题。高磷血症是透析患者的常见并发症。研究发现,高磷血症可导致血管钙化、内皮损伤,与透析患者死亡率密切相关[1-2],严重影响了透析患者生存时间及生活质量。因此,
CHEN Lei, JIANG Qiu-yan
doaj  

Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate

Therapeutics and Clinical Risk Management, 2008
Ismail A Mohammed, Alastair J HutchisonManchester Institute of Nephrology and Transplantation, Manchester Royal Infirmary, Oxford Road, Manchester, UKAbstract: Hyperphosphatemia is an inevitable consequence of end stage chronic kidney disease and is ...
Ismail A Mohammed, Alastair J Hutchison
doaj  

Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation – safety, efficacy, and patient adherence

Patient Preference and Adherence, 2013
MªJesús Lloret, César Ruiz-García, Iara DaSilva, Mónica Furlano, Yaima Barreiro, José Ballarín, Jordi Bover Nephrology Department, Fundació Puigvert, IIB Sant Pau, Barcelona, Spain; REDinREN ...
Lloret MJ, Ruiz-García C, DaSilva I, Furlano M, Barreiro Y, Ballarín J, Bover J   +6 more
doaj  

The effect of lanthanum carbonate on calciprotein particles in hemodialysis patients. [PDF]

Clin Exp Nephrol, 2020
Nakamura K, Nagata Y, Hiroyoshi T, Isoyama N, Fujikawa K, Miura Y, Matsuyama H, Kuro-O M.   +7 more
europepmc   +1 more source

Study on the Process and Mechanism of Preparing Lanthanum Carbonate from Rare Earth Chloride Solution. [PDF]

Materials (Basel)
Xu B, Lu W, Wang M, Song C, Sun X, Zhao Y.   +5 more
europepmc   +1 more source

Quantitative Visualization of Lanthanum Accumulation in Lanthanum Carbonate-Administered Human Stomach Tissues Using Mass Spectrometry Imaging. [PDF]

Mass Spectrom (Tokyo), 2020
Shimma S, Makino Y, Kojima K, Hirata T.
europepmc   +1 more source